These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 4985944)

  • 21. Chloroquine potentiation of thioridazine effects in rats and drug-resistant schizophrenic patients: a preliminary report.
    Traficante LJ; Hine B; Gershon S; Sakalis G
    Commun Psychopharmacol; 1977; 1(4):407-19. PubMed ID: 354856
    [No Abstract]   [Full Text] [Related]  

  • 22. [Clinical experiences with thiothixene (navane) in chronic schizophrenia].
    Gann G
    Wien Med Wochenschr; 1968 Jan; 118(1):10-3. PubMed ID: 5668801
    [No Abstract]   [Full Text] [Related]  

  • 23. Double blind comparative study of the effects of thiothixene and thioridazine in twenty chronic schizophrenic patients.
    Hardeman WJ; Bakker SJ
    Psychiatr Neurol Neurochir; 1970; 73(1):1-7. PubMed ID: 4907371
    [No Abstract]   [Full Text] [Related]  

  • 24. Piperacetazine (Quide): a controlled evaluation of the elixir in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1970 Jun; 12(6):387-9. PubMed ID: 4987346
    [No Abstract]   [Full Text] [Related]  

  • 25. An uncontrolled clinical study with piperacetazine in the maintenance treatment of chronic schizophrenic patients.
    Amin MM; Brahm E; Ban TA; Lehmann HE
    Psychopharmacol Bull; 1977 Jul; 13(3):10-1. PubMed ID: 18753
    [No Abstract]   [Full Text] [Related]  

  • 26. Predictor patterns in the management of therapy-resistant schizophrenia.
    Holden JM; Hsu W; Itil TM; Keskiner A
    Dis Nerv Syst; 1971 Apr; 32(4):260-8. PubMed ID: 4397410
    [No Abstract]   [Full Text] [Related]  

  • 27. Proceedings: A comparison of the therapeutic effect of oxypertine and thioridazine in chronic schizophrenia (a controlled trial).
    Remr J; Nekolová J; Heinzl Z
    Act Nerv Super (Praha); 1974; 16(4):261-2. PubMed ID: 4451005
    [No Abstract]   [Full Text] [Related]  

  • 28. Indications for phenothiazines in general practice and clinical trial with thioridazine.
    Tonken H
    Manit Med Rev; 1966 Dec; 46(10):630-3. PubMed ID: 5342555
    [No Abstract]   [Full Text] [Related]  

  • 29. [Alternating use of Melleril-Sandoz (thioridazine) and its metabolite Inofal in psychiatric treatment].
    Schwingenheuer J
    Med Welt; 1971 Oct; 43():1718-20. PubMed ID: 5132716
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparative trial of haloperidol and thioridazine: management of chronic schizophrenia.
    Weston MJ; Bentley R; Unwin A; Morris M; Harper MA
    Aust N Z J Psychiatry; 1973 Mar; 7(1):52-7. PubMed ID: 4579393
    [No Abstract]   [Full Text] [Related]  

  • 31. Quide vs. Mellaril in chronic schizophrenic patients.
    Gallant DM; Bishop MP
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):10-6. PubMed ID: 4621558
    [No Abstract]   [Full Text] [Related]  

  • 32. A controlled study of mesoridazine: an effective treatment for schizophrenia.
    McIndoo MV
    South Med J; 1971 May; 64(5):592-6. PubMed ID: 4929612
    [No Abstract]   [Full Text] [Related]  

  • 33. [Treatment of chronic schizophrenic psychoses with a thioridazine derivative].
    Glatzel J
    Med Welt; 1972 Jan; 23(2):62-4. PubMed ID: 5059991
    [No Abstract]   [Full Text] [Related]  

  • 34. Withdrawal of ataractic medication in schizophrenic patients.
    Garfield SL; Gershon S; Sletten I; Neubauer H; Ferrel E
    Dis Nerv Syst; 1966 May; 27(5):321-5. PubMed ID: 5327466
    [No Abstract]   [Full Text] [Related]  

  • 35. [Clinical-neuroleptic study of a thioridazine derivative (TPN 12) with special consideration of the neuroleptic threshold].
    Haase HJ; Bergener M; Hasselmeyer H
    Med Welt; 1967 Mar; 10():542-8. PubMed ID: 4870630
    [No Abstract]   [Full Text] [Related]  

  • 36. A study of thioridazine and its side-chain derivative, mesoridazine, in chronic male hospitalized psychiatric patients.
    Mena A; Grayson H; Cohen S
    J New Drugs; 1966; 6(6):345-8. PubMed ID: 5341416
    [No Abstract]   [Full Text] [Related]  

  • 37. [Comparative study of the activity of 2 neuroleptics].
    Blanc M; Borenstein P; Brion S; Buisson JF; Debray HR; Digo R; Flavigny H; Follin S; Minvielle J; Morel-Maroger A; Pichot P; Rainaut J; Sutter JM
    Encephale; 1970; 59(2):97-161. PubMed ID: 5458713
    [No Abstract]   [Full Text] [Related]  

  • 38. [Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
    Sizaret P; Anglade P; Simon JP
    Encephale; 1970; 59(3):278-88. PubMed ID: 5496123
    [No Abstract]   [Full Text] [Related]  

  • 39. Selective drug action related to chronic schizophrenic subtype. (A comparative study of carphenazine, chlorpromazine, and trifluoperazine).
    Platz AR; Klett CJ; Caffey EM
    Dis Nerv Syst; 1967 Sep; 28(9):601-5. PubMed ID: 4861216
    [No Abstract]   [Full Text] [Related]  

  • 40. Electrocardiographic evaluation of mesoridazine (Serentil).
    Dillenkoffer RL; Gallant DM; Phillips JH
    Curr Ther Res Clin Exp; 1972 Feb; 14(2):71-2. PubMed ID: 4622440
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.